Uses of the drug Oleanzrapitab 5

Oleanzrapitab 5 is researched and manufactured at Sun Pharmaceutical Industries Ltd with the main ingredient being Olanzapine. Oleanzrapitab 5 is used to treat schizophrenia and is available in the form of tablets in a box of 5 blisters x 10 tablets.

Oleanzrapitab 5 is used in the following cases:
Treatment of patients with schizophrenia Maintenance of clinical improvement while continuing treatment is very good in patients who have responded to initial treatment .

Oleanzrapitab 5 is used orally and is not dependent on meals. Dosage of the drug will depend on the age and medical condition of each person:
Olanzapine is taken once a day. Dosage starts from 5-10mg Olanzapine, after a few days can be used at a dose of 10mg/day. If necessary, the dose can be adjusted to no less than 1 week. However, titration to a dose higher than 10 mg/day requires careful clinical evaluation by the physician. Elderly: The starting dose is 5 mg/day for patients 65 years of age or older if there are clinical warnings. Oleanzrapitab 5 has not been studied in people < 18 years of age, and should not be used in children < 18 years of age. Patients with impaired liver and kidney function: The initial dose is usually as low as 5mg/day. In the presence of factors causing slow metabolism, a dose reduction should be considered. Dose escalation should follow the prescription from the doctor, pharmacist. Note: This is just a reference dose for patients. The specific dose depends on the condition and the course of the disease. For the right dosage, please consult your doctor, pharmacist or healthcare professional.

4.1. If you miss a dose, take it as soon as you remember it, as soon as possible. Accordingly, skip the missed dose if it is almost time for your next dose and take it as prescribed.
4.1. When patients take Olanzapine with a high dose of 300mg, some symptoms will occur such as: drowsiness, stuttering
Currently, there is a specific antidote for Olanzapine poisoning. In case of an emergency, the use of appropriate medical support should be initiated. Patients should consider the possibility of toxicity before combining multiple drugs, establish and maintain an airway, and ensure adequate oxygenation and ventilation. The use of activated charcoal should be considered, as it may reduce the bioavailability of olanzapine by 50-60%. The use of gastric lavage may be considered.
Hypotension and shock should be treated with intravenous fluids or sympathomimetic agents. Close cardiovascular monitoring is required until the patient recovers.

Oleanzrapitab 5 should not be used in the following cases:
Patients with hypersensitivity to Olanzapine or any of its ingredients. Patients with known risk of narrow-angle glaucoma.

During the use of Oleanzrapitab 5, patients may experience some unwanted side effects such as:
Drowsiness Weight gain, increased appetite Dry mouth Lower blood pressure orthostatic edema Peripheral edema Increased liver enzymes AST, ALT Sensitive to light Milk Nipple Enlarged mammary gland Feminine gynecomastia. Elevated levels of the enzyme Creatine Phosphokinase Hematologic changes If during the use of Olanzapine, the patient encounters any adverse effects. Immediately notify your doctor, pharmacist for appropriate support and treatment.

Use caution when taking Oleanzrapitab 5 with the following drugs:
Olanzapine co-administration with activated charcoal may reduce the bioavailability of Olanzapine. Decreased clearance and increased half-life of Olanzapine when co-administered with tobacco. Increased clearance and half-life of Olanzapine when combined with Carbamazepine. Do not take Olanzapine with non-Lithium or Biperiden.

In the process of using Oleanzrapitab 5, patients should note:
In case of using Olanzapine for pregnant women, it is necessary to consult a doctor, because currently there are no accurate reports of effects on pregnant women. pregnant. Olanzapine has been reported to be excreted in the milk of rats. However, it is not known whether Olanzapine is excreted in human milk. Patients should consult before using the drug if they are breast-feeding. Olanzapine side effects can be drowsiness. Therefore, patients should be very careful when taking Olanzapine while driving and operating machinery. Oleanzrapitab 5 is a prescription drug, so patients are not allowed to buy and use it on their own. Olanzapine should be used with caution in patients with prostatic hypertrophy, elevated liver enzymes, impaired liver function, semi-ileal obstruction, leukopenia, polymorphonuclear leukopenia, convulsions, epilepsy, abnormally increased interval QT on electrocardiogram. Store the medicine in a cool, dry place with the most appropriate temperature <30 degrees Celsius. Keep out of reach of children. Oleanzrapitab 5 has the main ingredient Olanzapine, which is indicated for the treatment of schizophrenia. To ensure effective treatment and avoid unwanted side effects, patients need to take the medicine exactly as directed.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.